Loading…
Effects of beta thalassemia minor on results of six glycated hemoglobin methods
Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM. Samples sub...
Saved in:
Published in: | Clinica chimica acta 2004-12, Vol.350 (1), p.123-128 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3 |
---|---|
cites | cdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3 |
container_end_page | 128 |
container_issue | 1 |
container_start_page | 123 |
container_title | Clinica chimica acta |
container_volume | 350 |
creator | Polage, Christopher Little, Randie R. Rohlfing, Curt L. Cole, Thomas G. Roberts, William L. |
description | Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM.
Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays.
The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 (
p=0.051). Further investigation demonstrated an increase in Synchron %HbA
1c results with decreasing hemoglobin concentrations.
In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem. |
doi_str_mv | 10.1016/j.cccn.2004.07.015 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67047917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898104003766</els_id><sourcerecordid>67047917</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</originalsourceid><addsrcrecordid>eNp9kM9LwzAUx4Mobk7_AQ-Sk7fWlyZtWvAiMn_AYBc9hzR92TLaZiaduP_ejg28eXg8Hny-X3gfQm4ZpAxY8bBJjTF9mgGIFGQKLD8jU1ZKnnBRZedkCgBVUlYlm5CrGDfjKaBgl2TC8pyDKMopWc6tRTNE6i2tcdB0WOtWx4id07RzvQ_U9zRg3LVHKLofumr3Rg_Y0DV2ftX62vW0w2Htm3hNLqxuI96c9ox8vsw_nt-SxfL1_flpkRieZ0OSmVyiYBatBgtmHDCFkcgzbrDGmjelrhsuTZaXUou6QSyE4LKWIhPaWj4j98febfBfO4yD6lw02La6R7-LqpAgZMXkCGZH0AQfY0CrtsF1OuwVA3XQqDbqoFEdNCqQatQ4hu5O7bu6w-YvcvI2Ao9HAMcfvx0GFY3D3mDjwqhTNd791_8LD2KFDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67047917</pqid></control><display><type>article</type><title>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</title><source>ScienceDirect Journals</source><creator>Polage, Christopher ; Little, Randie R. ; Rohlfing, Curt L. ; Cole, Thomas G. ; Roberts, William L.</creator><creatorcontrib>Polage, Christopher ; Little, Randie R. ; Rohlfing, Curt L. ; Cole, Thomas G. ; Roberts, William L.</creatorcontrib><description>Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM.
Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays.
The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 (
p=0.051). Further investigation demonstrated an increase in Synchron %HbA
1c results with decreasing hemoglobin concentrations.
In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cccn.2004.07.015</identifier><identifier>PMID: 15530468</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Anemia ; Beta thalassemia minor ; beta-Thalassemia - metabolism ; Biological Assay - methods ; Diabetes Mellitus, Type 1 - blood ; Evaluation Studies as Topic ; False elevation ; Glycated hemoglobin ; Glycated Hemoglobin A - analysis ; Glycated Hemoglobin A - metabolism ; HbA 1c ; Hematologic Tests - methods ; Humans ; Phenotype ; Regression Analysis ; Sensitivity and Specificity</subject><ispartof>Clinica chimica acta, 2004-12, Vol.350 (1), p.123-128</ispartof><rights>2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</citedby><cites>FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15530468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Polage, Christopher</creatorcontrib><creatorcontrib>Little, Randie R.</creatorcontrib><creatorcontrib>Rohlfing, Curt L.</creatorcontrib><creatorcontrib>Cole, Thomas G.</creatorcontrib><creatorcontrib>Roberts, William L.</creatorcontrib><title>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM.
Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays.
The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 (
p=0.051). Further investigation demonstrated an increase in Synchron %HbA
1c results with decreasing hemoglobin concentrations.
In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.</description><subject>Adult</subject><subject>Anemia</subject><subject>Beta thalassemia minor</subject><subject>beta-Thalassemia - metabolism</subject><subject>Biological Assay - methods</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Evaluation Studies as Topic</subject><subject>False elevation</subject><subject>Glycated hemoglobin</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>HbA 1c</subject><subject>Hematologic Tests - methods</subject><subject>Humans</subject><subject>Phenotype</subject><subject>Regression Analysis</subject><subject>Sensitivity and Specificity</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp9kM9LwzAUx4Mobk7_AQ-Sk7fWlyZtWvAiMn_AYBc9hzR92TLaZiaduP_ejg28eXg8Hny-X3gfQm4ZpAxY8bBJjTF9mgGIFGQKLD8jU1ZKnnBRZedkCgBVUlYlm5CrGDfjKaBgl2TC8pyDKMopWc6tRTNE6i2tcdB0WOtWx4id07RzvQ_U9zRg3LVHKLofumr3Rg_Y0DV2ftX62vW0w2Htm3hNLqxuI96c9ox8vsw_nt-SxfL1_flpkRieZ0OSmVyiYBatBgtmHDCFkcgzbrDGmjelrhsuTZaXUou6QSyE4LKWIhPaWj4j98febfBfO4yD6lw02La6R7-LqpAgZMXkCGZH0AQfY0CrtsF1OuwVA3XQqDbqoFEdNCqQatQ4hu5O7bu6w-YvcvI2Ao9HAMcfvx0GFY3D3mDjwqhTNd791_8LD2KFDQ</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Polage, Christopher</creator><creator>Little, Randie R.</creator><creator>Rohlfing, Curt L.</creator><creator>Cole, Thomas G.</creator><creator>Roberts, William L.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</title><author>Polage, Christopher ; Little, Randie R. ; Rohlfing, Curt L. ; Cole, Thomas G. ; Roberts, William L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Anemia</topic><topic>Beta thalassemia minor</topic><topic>beta-Thalassemia - metabolism</topic><topic>Biological Assay - methods</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Evaluation Studies as Topic</topic><topic>False elevation</topic><topic>Glycated hemoglobin</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>HbA 1c</topic><topic>Hematologic Tests - methods</topic><topic>Humans</topic><topic>Phenotype</topic><topic>Regression Analysis</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Polage, Christopher</creatorcontrib><creatorcontrib>Little, Randie R.</creatorcontrib><creatorcontrib>Rohlfing, Curt L.</creatorcontrib><creatorcontrib>Cole, Thomas G.</creatorcontrib><creatorcontrib>Roberts, William L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Polage, Christopher</au><au>Little, Randie R.</au><au>Rohlfing, Curt L.</au><au>Cole, Thomas G.</au><au>Roberts, William L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of beta thalassemia minor on results of six glycated hemoglobin methods</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>350</volume><issue>1</issue><spage>123</spage><epage>128</epage><pages>123-128</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>Beta-thalassemia minor (BTM) is a common benign condition that can be present in patients with diabetes mellitus. There are conflicting reports about the effect of BTM on glycated hemoglobin (gHb) measurements. We evaluated 6 gHb methods using samples from non-diabetic subjects with BTM.
Samples submitted for hemoglobin phenotype analysis were evaluated. A total of 57 samples (30 controls and 27 with BTM) from non-diabetic subjects were selected. GHb analysis was performed by Tosoh A1c 2.2+, Primus CLC 330, Bayer DCA 2000, Beckman Coulter, Synchron CX7 and LX20, and Roche Tina-quant II assays.
The A1c 2.2+, CLC 330, DCA 2000 and Tina-quant II assays showed no statistically significant difference between the control and BTM groups. In contrast, BTM results were significantly higher than controls on the Synchron CX7 analyzer and borderline significant on the Synchron LX20 (
p=0.051). Further investigation demonstrated an increase in Synchron %HbA
1c results with decreasing hemoglobin concentrations.
In this study using samples from subjects with normal or near-normal gHb, BTM does not affect gHb measurements per se. However, the Synchron methods yielded higher results for samples with lower hemoglobin concentrations, like those that can be seen in BTM. The Synchron method was improved at the end of 2003, which minimized this problem.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>15530468</pmid><doi>10.1016/j.cccn.2004.07.015</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-8981 |
ispartof | Clinica chimica acta, 2004-12, Vol.350 (1), p.123-128 |
issn | 0009-8981 1873-3492 |
language | eng |
recordid | cdi_proquest_miscellaneous_67047917 |
source | ScienceDirect Journals |
subjects | Adult Anemia Beta thalassemia minor beta-Thalassemia - metabolism Biological Assay - methods Diabetes Mellitus, Type 1 - blood Evaluation Studies as Topic False elevation Glycated hemoglobin Glycated Hemoglobin A - analysis Glycated Hemoglobin A - metabolism HbA 1c Hematologic Tests - methods Humans Phenotype Regression Analysis Sensitivity and Specificity |
title | Effects of beta thalassemia minor on results of six glycated hemoglobin methods |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T21%3A53%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20beta%20thalassemia%20minor%20on%20results%20of%20six%20glycated%20hemoglobin%20methods&rft.jtitle=Clinica%20chimica%20acta&rft.au=Polage,%20Christopher&rft.date=2004-12-01&rft.volume=350&rft.issue=1&rft.spage=123&rft.epage=128&rft.pages=123-128&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cccn.2004.07.015&rft_dat=%3Cproquest_cross%3E67047917%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c352t-2c57e41fefa0f0c0f00c6c7e323cebeb3d8abd37c2587a4bdee64437b7424aff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67047917&rft_id=info:pmid/15530468&rfr_iscdi=true |